In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Rigel completes 5.65mm-share IPO

Executive Summary

After withdrawing an initial public offering for up to $100mm earlier this year, Rigel Pharmaceuticals (functional genomics, combinatorial biology) netted $35.8mm in its IPO of 5.65mm shares (including the overallotment) at $7 each--this time it had hoped to sell 9mm shares at a price range of $8-10.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
      • Molecular Diversity
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies